The global multivitamin market has transitioned from a basic nutritional "safety net" to a highly sophisticated, multi-billion dollar pillar of the preventative healthcare industry. As of 2024, the market is characterized by a shift toward science-backed formulations and therapeutic-grade supplements. Rapidly aging populations in Europe and East Asia, combined with a post-pandemic surge in immune-awareness, have created a permanent floor for high-demand nutritional products.
Industrial manufacturing of multivitamins now involves complex biochemical synthesis, fermentation, and nanotechnology to enhance bioavailability. Leading manufacturers are no longer just mixing powders; they are architects of molecular stability, ensuring that sensitive compounds like Vitamin B12 and Vitamin C remain potent throughout their shelf life in various delivery formats.
Artificial intelligence is being used to analyze vast datasets of human deficiency patterns to create "Hyper-Personalized" multivitamin blends tailored to specific genetic profiles and lifestyles.
The rise of liposomal technology and nano-emulsions allows multivitamins to bypass the digestive degradation, offering up to 5x higher absorption rates than traditional tablets.
Global procurers are demanding "Clean Label" products: non-GMO, vegan-certified, and ethically sourced raw materials with full traceability from the farm to the pharmacy shelf.
Xian QLU Health Pharmaceutical Technology Co., Ltd. engaged in the development, production and marketing of pharmaceutical products, food ingredients, vitamins, intermediates and chemicals.
QLU headquartered in Xian, China, with 3 production bases in Shandong, Zhejiang and Hebei separately, which have many years of experience in the production of APIs, vitamins and chemical products. These facilities have been certified GMP, ISO, FAMI-QS, KOSHER, HALAL, etc. We have complete control over our product development, design, and manufacturing processes, thanks to our advanced equipment, methods, and inspection facilities.
With key competencies in pharmaceuticals and food health, Richer Pharma has established extensive business networks around the world. We have Strategic Marketing Partners respectively in Mumbai and Dubai. We are ready to provide you with our best products and services.
In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies, actively adopt new scientific advancements, and continuously evolve to meet the evolving needs of patients and healthcare providers.
Focus on pharmaceutical products, food ingredients, vitamins.
Engaged in marketing of APIs, ingredients, vitamins, intermediates.
Engaged in production and marketing of APIs, ingredients, vitamins, intermediates.
Devoted to the development, production and marketing of all kinds of APIs and chemicals.
Large-scale pharmaceutical distributors and retail chains look for "One-Stop" manufacturers. Our ability to supply both the API (Active Pharmaceutical Ingredient) and the finished dosage form (Softgel, Tablet, Capsule) significantly reduces supply chain risks and logistics costs for global buyers.
Localized applications in Europe and North America focus on sports-specific multivitamins. We provide customized formulations containing Electrolytes, B-Complex, and Branched-Chain Amino Acids (BCAAs) to support high-intensity athletic recovery.
In regions with high livestock density like South America and Australia, our Vitamin-Antibiotic soluble powders are critical for poultry and pig health management, demonstrating the versatility of our multivitamin industrial applications.
As a leading China Multivitamins Manufacturer, Xian QLU Health leverages the world's most robust industrial supply chain. China currently produces over 70% of the world's Vitamin C and a significant portion of the global B-Vitamin and D3 supply. By manufacturing at the source, we offer:
QLU Health
